optivalue.ai
Questionnaires, audits, and RFPs consume a significant amount of your experts' time. Turn this administrative burden into an engine to win.
Optivalue.ai reduces response times by up to 90% by automating information discovery and response drafting, allowing your experts to focus on the high-impact personalization that wins bids.
Here's how it works:
Understanding: Connected to your systems, it acts as an expert librarian. It reads and understands your entire knowledge base to know precisely where the best information is for any question.
Submission: You submit a questionnaire to it.
Response: In minutes, it generates a complete draft response using the most relevant excerpts from your own documents.
Every answer becomes a verified fact. For perfect traceability, every statement is substantiated. Optivalue.ai precisely cites the source document, page, and date. You don't just answer correctly—you prove it.
It’s an engine for organizational improvement. Optivalue.ai performs a gap analysis to identify weaknesses in your documentation. The proposed improvements build your team's expertise. By implementing these recommendations to update your internal documents, you drive lasting progress across your entire organization.
Your data security is guaranteed. Optivalue.ai is built with enterprise-grade security, compliant with strict standards like GDPR, HIPAA, ISO, and FedRAMP, allowing you to manage your most sensitive data with complete confidence.
All our plans include unlimited users and projects.
Start your 14-day free trial.
No credit card required. No commitment.
Learn more
SenseIP
senseIP streamlines the patenting process by providing a complete AI-driven solution for inventors. The platform supports everything from researching prior art and drafting patents to filing and managing patents, all without requiring legal expertise. With senseIP, users can access advanced AI tools that accelerate the patent process, offering accurate results at a fraction of the cost of traditional patent law services. The platform is trained on over 100 million patent applications globally, ensuring precise and high-quality outcomes for both startups and individual inventors.
Learn more
Qmarkets
Managing innovation at a large company can sometimes seem impossible. You have an endless list of stakeholders to engage, an infinite number of data points to consider, and a multitude of obstacles and landmines to avoid...
To overcome all of these challenges and revolutionize your business, you need the right tools for the job. This is where Qmarkets comes in.
Our software enables you to define and manage intelligent crowdsourcing processes to identify, review, and implement the most relevant ideas, trends, or insights, and deliver immediate ROI for your organization.
The Qmarkets Innovation Management Ecosystem caters to every innovation use case, with specific software solutions for idea management, continuous improvement, technology scouting, trend management, and innovation portfolio management.
With renowned clients like Ford, Intel, Coca-Cola, Volkswagen and UBS, we have a wealth of best-practices and insight to help your organization to achieve its goals. Whichever path you choose, we are obsessed with your success, and will be with you at every step of your innovation journey.
Learn more
Patsnap
Patsnap, the leading innovation intelligence platform, helps you identify technology opportunities that can affect the future growth and success of your business. Patsnap uses AI technology to extract actionable intelligence from millions global innovation data points, including patents, venture funding, partnerships, journals and startups, mergers and acquisitions, technology information, and more. Patsnap helps you make better decisions at each stage of your innovation funnel, from ideation to commercialization. Our AI-powered technology allows innovation professionals uncover emerging trends, identify risks, and identify opportunities. Patsnap connects disparate datapoints to drive drug discovery and research. Discover associations between diseases, companies and drugs, while improving R&D, and accelerating the time to market.
Learn more